Disparity in use of modern combination chemotherapy associated with facility type influences survival of 2655 patients with advanced pancreatic cancer.

Morten LadekarlLouise Skau RasmussenJakob KirkegårdInna ChenPer PfeifferBritta WeberHalla SkuladottirKell ØsterlindJim Stenfatt LarsenFrank Viborg MortensenHenriette EngbergHenrik MøllerClaus Wilki Fristrup

Published in: Acta oncologica (Stockholm, Sweden) (2021)

Equal access to modern combination chemotherapy at all facilities on a national level is essential to ensure equality in treatment results.

Keyphrases

locally advanced
quality improvement
squamous cell carcinoma
rectal cancer
free survival